Vaccinex, Inc.
OTC: VCNX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Maurice Zauderer
- Employees
- 23
- Headquarters
- Rochester, United States
- IPO year
- 2018
- Market cap
- $2.1M
- Website
- https://www.vaccinex.com
Loading VCNX…
Loading profile data…Frequently asked questions about VCNX
What does Vaccinex, Inc. (VCNX) do?
Vaccinex, Inc. is a biotechnology firm operating in the clinical stage, dedicated to identifying and developing specialized biological therapies. Its core mission is to address serious medical conditions and diseases that currently lack adequate treatment options. The company's therapeutic endeavors encompass a broad spectrum of illnesses, inclu...
Where does VCNX trade?
Vaccinex, Inc. (VCNX) trades on the Other OTC.
What sector is VCNX in?
Vaccinex, Inc. (VCNX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vaccinex, Inc.?
Maurice Zauderer is the chief executive officer of Vaccinex, Inc. (VCNX).
Where is Vaccinex, Inc. headquartered?
Vaccinex, Inc. is headquartered in United States.
Does VCNX pay a dividend?
Vaccinex, Inc. (VCNX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VCNX go public?
Vaccinex, Inc. (VCNX) completed its initial public offering in 2018.